Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isolation and characterization of single domain antibodies from banded houndshark (Triakis scyllium) targeting SARS-CoV-2 spike RBD protein.
Kim WS, Chae HD, Jung I, Lee WK, Lee WJ, Lee J, Gong Y, Lee D, Kim BW, Kim JK, Hwang J, Kweon DH, Jung ST, Na JH. Kim WS, et al. Among authors: kim jk, kim bw. Fish Shellfish Immunol. 2023 Jul;138:108807. doi: 10.1016/j.fsi.2023.108807. Epub 2023 May 9. Fish Shellfish Immunol. 2023. PMID: 37169112 Free PMC article.
Contemporary diagnosis and treatment of valvular heart disease in Korea: a nationwide hospital-based registry study.
Kim HY, Lee HJ, Kim IC, Son JW, Park JB, Lee S, Kim EK, Park SM, Chung WB, Cho JS, Park JS, Seo JS, Lee SH, Sun BJ, Shim CY, Kim H, Kim KH, Kang DH, Ha JW; Korean Valve Survey Registry Investigators. Kim HY, et al. J Cardiovasc Imaging. 2024 Nov 22;32(1):37. doi: 10.1186/s44348-024-00036-z. J Cardiovasc Imaging. 2024. PMID: 39574207 Free PMC article.
Outcomes after percutaneous coronary intervention or bypass surgery for ischemic cardiomyopathy.
Kwon W, Kim O, Choi KH, Jeong DS, Lee SY, Lee JM, Park TK, Yang JH, Hahn JY, Choi SH, Chung SR, Cho YH, Sung K, Kim WS, Gwon HC, Lee YT, Song YB. Kwon W, et al. Among authors: kim ws. Rev Esp Cardiol (Engl Ed). 2024 Nov 19:S1885-5857(24)00334-7. doi: 10.1016/j.rec.2024.11.003. Online ahead of print. Rev Esp Cardiol (Engl Ed). 2024. PMID: 39566819 English, Spanish.
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.
Abramson JS, Ku M, Hertzberg M, Huang HQ, Fox CP, Zhang H, Yoon DH, Kim WS, Abdulhaq H, Townsend W, Herbaux C, Zaucha JM, Zhang QY, Chang H, Liu Y, Cheah CY, Ghesquieres H, Simko S, Orellana-Noia V, Ta R, Relf J, Dixon M, Kallemeijn M, Mulvihill E, Huang H, Lundberg L, Gregory GP. Abramson JS, et al. Among authors: kim ws. Lancet. 2024 Nov 16;404(10466):1940-1954. doi: 10.1016/S0140-6736(24)01774-4. Lancet. 2024. PMID: 39550172 Clinical Trial.
2,839 results